1. Home
  2. NEO

NEO

NeoGenomics Inc.

Logo NeoGenomics Inc.

Health Care

Precision Instruments

Nasdaq

as 04-19-2024 4:00pm EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

NeoGenomics Inc operates a network of cancer-focused genetic testing laboratories in the United States as well as a laboratory in Switzerland. The company operates into two segments namely Clinical Services and Advanced Diagnostics. It offers types of genetic and molecular testing services namely Cytogenetics, Fluorescence In-Situ Hybridization, Flow cytometry, Immunohistochemistry, Molecular testing, Pathology consultation. Advanced Diagnostics segment supports pharmaceutical firms in their drug development programs by supporting various clinical trials and research. For Clinical Services, Its specialized diagnostic services are performed based on an online test order or a written test requisition form. The company generates majority of its revenue from Clinical Services.

Founded: 2001 Country:
United States
United States
Employees: N/A City: FORT MYERS
Market Cap: 1.8B IPO Year: 1999
Target Price: $19.22 AVG Volume (30 days): 908.6K
Analyst Decision: Buy Number of Analysts: 10
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.70 EPS Growth: N/A
52 Week Low/High: $11.03 - $21.22 Next Earning Date: 04-30-2024
Revenue: $591,643,000 Revenue Growth: 16.07%
Revenue Growth (this year): 11.74% Revenue Growth (next year): 9.76%

Share on Social Networks: